These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25985851)

  • 1. The Effect of Vitamin A Supplementation on FoxP3 and TGF-β Gene Expression in Avonex-Treated Multiple Sclerosis Patients.
    Saboor-Yaraghi AA; Harirchian MH; Mohammadzadeh Honarvar N; Bitarafan S; Abdolahi M; Siassi F; Salehi E; Sahraian MA; Eshraghian MR; Roostaei T; Koohdani F
    J Mol Neurosci; 2015 Jul; 56(3):608-12. PubMed ID: 25985851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
    Mohammadzadeh Honarvar N; Harirchian MH; Abdolahi M; Abedi E; Bitarafan S; Koohdani F; Siassi F; Sahraian MA; Chahardoli R; Zareei M; Salehi E; Geranmehr M; Saboor-Yaraghi AA
    J Mol Neurosci; 2016 Jul; 59(3):360-5. PubMed ID: 27122150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of vitamin A supplementation on Foxp3 and TGF-β gene expression in atherosclerotic patients.
    Mottaghi A; Salehi E; Keshvarz A; Sezavar H; Saboor-Yaraghi AA
    J Nutrigenet Nutrigenomics; 2012; 5(6):314-26. PubMed ID: 23363776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
    Balasa R; Maier S; Voidazan S; Hutanu A; Bajko Z; Motataianu A
    CNS Neurol Disord Drug Targets; 2015; 14(6):804-10. PubMed ID: 25801840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of retinyl-palmitate on the level of pro and anti-inflammatory cytokines in multiple sclerosis patients: A randomized double blind clinical trial.
    Bitarafan S; Mohammadpour Z; Jafarirad S; Harirchian MH; Yekaninejad MS; Saboor-Yaraghi AA
    Clin Neurol Neurosurg; 2019 Feb; 177():101-105. PubMed ID: 30640138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Regulatory T-Cells in Multiple Sclerosis Patients Treated with Interferon Beta-1a.
    Ebrahimimonfared M; Ganji A; Zahedi S; Nourbakhsh P; Ghasami K; Mosayebi G
    CNS Neurol Disord Drug Targets; 2018; 17(2):113-118. PubMed ID: 29589548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis.
    Lozano-Ros A; Martínez-Ginés ML; García-Domínguez JM; Salvador-Martín S; Goicochea-Briceño H; Cuello JP; Meldaña-Rivera A; Higueras-Hernández Y; Sanjurjo-Sáez M; Álvarez-Sala-Walther LA; López-Fernández LA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
    Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
    Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
    Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
    Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune regulatory effects of high dose vitamin D
    Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
    J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vitamin A supplementation on retinoic acid-related orphan receptor γt (RORγt) and interleukin-17 (IL-17) gene expression in Avonex-treated multiple sclerotic patients.
    Mohammadzadeh Honarvar N; Harirchian MH; Koohdani F; Siassi F; Abdolahi M; Bitarafan S; Salehi E; Sahraian MA; Eshraghian MR; Saboor-Yarghi AA
    J Mol Neurosci; 2013 Nov; 51(3):749-53. PubMed ID: 23868508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
    Bitarafan S; Saboor-Yaraghi A; Sahraian MA; Soltani D; Nafissi S; Togha M; Beladi Moghadam N; Roostaei T; Mohammadzadeh Honarvar N; Harirchian MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):13-9. PubMed ID: 26996107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vitamin A supplementation on RAR gene expression in multiple sclerosis patients.
    Bitarafan S; Harirchian MH; Sahraian MA; Keramatipour M; Beladi Moghadam N; Togha M; Nafissi S; Siassi F; Eshraghian MR; Mohammadzadeh Honarvar N; Ansar H; Talebi S; Saboor-Yarghi AA
    J Mol Neurosci; 2013 Oct; 51(2):478-84. PubMed ID: 23955709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
    Holmøy T; Røsjø E; Zetterberg H; Blennow K; Lindstrøm JC; Steffensen LH; Kampman MT
    Acta Neurol Scand; 2019 Feb; 139(2):172-176. PubMed ID: 30317548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin A supplementation reduces the Th17-Treg - Related cytokines in obese and non-obese women.
    Farhangi MA; Saboor-Yaraghi AA; Keshavarz SA
    Arch Endocrinol Metab; 2016 Feb; 60(1):29-35. PubMed ID: 26909479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis.
    Bitarafan S; Saboor-Yaraghi A; Sahraian MA; Nafissi S; Togha M; Beladi Moghadam N; Roostaei T; Siassi F; Eshraghian MR; Ghanaati H; Jafarirad S; Rafiei B; Harirchian MH
    Arch Iran Med; 2015 Jul; 18(7):435-40. PubMed ID: 26161708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
    Namdar A; Nikbin B; Ghabaee M; Bayati A; Izad M
    J Neuroimmunol; 2010 Jan; 218(1-2):120-4. PubMed ID: 19932513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin A supplementation leads to increases in regulatory CD4+Foxp3+LAP+ T cells in mice.
    Medeiros SR; Pinheiro-Rosa N; Lemos L; Loli FG; Pereira AG; Santiago AF; Pinter EC; Alves AC; Oliveira JS; Cara DC; Maioli TU; Faria AM
    Nutrition; 2015 Oct; 31(10):1260-5. PubMed ID: 26004193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
    Kleinschnitz C; Niemczyk G; Rehberg-Weber K; Wernsdörfer C
    Int J Mol Sci; 2015 Jul; 16(7):15271-86. PubMed ID: 26154767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
    J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.